Chemical Structure (Ampyra 01)
Ampyra Tablet, Film Coated, Extended Release
Product Images NDC 10144-427
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ampyra (NDC 10144-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merz Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Ampyra 02)
The text is describing a chart showing the percentage of patients with different treatments. The treatments are QFiscebo (represented by a value of 1 and 72 patients), and BAMPYRA 10 mg bid (represented by a value of 1 and 229 patients). The chart also includes the average percentage increase in walking speed from baseline for each treatment, which ranges from 210% to 250%.*
Figure 2 (Ampyra 03)
This appears to be a table or a chart showing data on patients and their walking speed. It is not clear what the top row signifies, but it seems to be a percentage of patients. The following rows contain percentages as well, probably representing different groups of patients. The last row shows the average percent increase in walking speed from baseline in different time intervals or under different treatments. There are also mentions of "@Placebo" and "@AUPTRA Dmg bid". Without more context, it is difficult to interpret and provide a more specific description of the chart.*
Sharp-bottle (Ampyra Bottle Sharp10 16)
This is a description of a medication called dalfampridine in extended release tablet form. The tablets come in a container with a child resistant closure, and each tablet contains 10mg of dalfampridine. The dosage information can be found in the package insert, and the tablets should not be divided, crushed, chewed or dissolved. The recommended storage temperature is 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). The pharmacist should dispense the accompanying Medication Guide to each patient. The provided code is 10144 42760 2, and there are 60 tablets in each pack.*
Crcl-eqn-102716.jpg (Crcl Eqn 102716)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
